MIT researchers have found two defective genes that interact in tumors to determine how patients will respond to chemotherapy, according to the school. Biology professors Michael Hemann and Michael Yaffe, who ran the study, said the research could help doctors tailor chemotherapy treatments to particular kinds of tumors.
Promising cancer treatment breakthroughs are usually tempered by delays brought on by testing and regulations. This discovery, however, should be ready for use, according to the reseachers:
“This isn’t something that’s going to take five years to do,” says Yaffe, who, along with Hemann is a member of the David H. Koch Institute for Integrative Cancer Research at MIT. “You could begin doing this tomorrow.”The work could also guide the development of new chemotherapy drugs targeted to tumors with specific genetic mutations.
Posted by Brendan Lynch
Tags: cancer, chemotherapy, Koch Institute for Integrative Cancer Research, Michael Hemann, Michael Yaffe, MIT
RSS Feeds
Habbo Retros…
Habbo Retros are slowly attracting more users with each passing day, most people prefer to play Habbo Retros with pets according to a recent google study, further evidence also supports that Habbo Retros have lead to an annual decrease in revenue for s…